Aspirin for primary prevention : Treatment policy should be based on all trial evidence, not subgroup analysis

Documenti analoghi

• Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
  di: Sanmuganathan, P, et al.
  Pubblicazione: (2001)
• Aspirin for primary prevention of coronary heart disease
  di: Jackson, Peter PR, et al.
  Pubblicazione: (2004)
• Statins for primary prevention: at what coronary risk is safety assured?
  di: Jackson, Peter R, et al.
  Pubblicazione: (2001)
• The death of aspirin for primary prevention—should aspirin be changed to a prescription only medication?
  di: Rawal, Aranyak, et al.
  Pubblicazione: (2019)
• Statins and primary prevention: Is all the evidence in?
  di: Rashid, Shirya, et al.
  Pubblicazione: (2008)